About
Endomedix, Inc. is an early-stage medical device company located in Montclair, New Jersey. Founded in July 2014, the company specializes in biosurgery solutions, utilizing its proprietary PLEXimine chemistry platform to create innovative medical devices for neurosurgery and spinal surgery. With a small team of fewer than 25 employees, Endomedix is focused on developing its flagship product, PlexiClot, a hydrogel-based device designed to control bleeding during surgical procedures. PlexiClot is engineered to be applied directly at the surgical site, addressing a critical challenge in neurosurgery: controlling bleeding, which can lead to complications and additional surgeries. The technology is based on biologically derived polysaccharides, known for their safe use in medical applications. Endomedix aims to reduce hospital costs by preventing complications and improving patient outcomes, targeting hospitals and surgical centers that perform high-risk procedures. The company is actively working to bring its products to market, with its technology currently in the prototype stage and approaching pre-launch.
Technologies
Keywords
Company Information
-
Employees 5
-
Founded 2014
-
Annual Revenue $48324000
-
Total Funding $1186951
Location
1 Normal Ave, Montclair, New Jersey, United States, 07043